Abstract
Quercetin, a natural flavonoid, exhibits anticancer effects. The aim of this study is to determine whether the combination of quercetin with cisplatin, a conventional chemotherapeutic drug, would have synergistic suppressive effects on hepatocellular carcinoma (HCC) cells. To this end, HepG2 cells were exposed to quercetin (50 μM) or cisplatin (10 μM) alone or combination of both and cell proliferation and apoptosis were investigated. Our data revealed that the combination of quercetin and cisplatin was significantly (P < 0.05) effective in inducing growth suppression and apoptosis in HepG2 cells, when compared with single agent treatment. Quercetin combined with cisplatin modulated the expression of numerous genes involved in cell cycle progression and apoptosis. Treatment with quercetin rather than cisplatin resulted in a marked elevation of p16 expression in HepG2 cells. Targeted reduction of p16 using RNA interference technology partially reversed quercetin-induced cell cycle G1 arrest and apoptosis in HepG2 cells. In conclusion, quercetin has suppressive activity against HCC cells through p16-mediated cell cycle arrest and apoptosis and its combination with cisplatin yielded synergistic inhibitory effects in suppressing cell growth and inducing apoptosis.
Similar content being viewed by others
References
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). CA: A Cancer Journal for Clinicians, 55, 74–108.
Farazi, P. A., & DePinho, R. A. (2006). Nature Reviews Cancer, 6, 674–687.
Sadowitz, P. D., Hubbard, B. A., Dabrowiak, J. C., Goodisman, J., Tacka, K. A., Aktas, M. K., et al. (2002). Drug Metabolism and Disposition, 30, 183–190.
Carr, B. I., Bron, K., & Swanson, D. P. (2011). Journal of Clinical Gastroenterology, 45, e87–e91.
Yamanaka, K., Hatano, E., Narita, M., Taura, K., Yasuchika, K., Nitta, T., et al. (2011). Hepatology Research, 41, 303–309.
Yang, J. X., Luo, Y., Qiu, H. M., & Tang, W. X. (2009). Saudi Medical Journal, 30, 35–40.
Dong, Z., & Atherton, S. S. (2007). Kidney International, 72, 5–7.
Gibellini, L., Pinti, M., Nasi, M., Montagna, J. P., De Biasi, S., Roat, E., et al. (2011). Evidence-based Complementary and Alternative Medicine, 2011, 591356.
Chuang-Xin, L., Wen-Yu, W., Yao, C., Xiao-Yan, L., & Yun, Z. (2012). Oncology Letters, 4, 775–778.
Angst, E., Park, J. L., Moro, A., Lu, Q. Y., Lu, X., Li, G., et al. (2013). Pancreas, 42, 223–229.
Zhang, H., Zhang, M., Yu, L., Zhao, Y., He, N., & Yang, X. (2012). Food and Chemical Toxicology, 50, 1589–1599.
Mu, C., Jia, P., Yan, Z., Liu, X., Li, X., & Liu, H. (2007). Methods and Findings in Experimental and Clinical Pharmacology, 29, 179–183.
Duo, J., Ying, G. G., Wang, G. W., & Zhang, L. (2012). Molecular Medicine Reports, 5, 1453–1456.
Tan, J., Wang, B., & Zhu, L. (2009). Chemistry and Biodiversity, 6, 1101–1110.
Staedler, D., Idrizi, E., Kenzaoui, B. H., & Juillerat-Jeanneret, L. (2011). Cancer Chemotherapy and Pharmacology, 68, 1161–1172.
Qin, L. F., & Ng, I. O. (2002). Cancer Letters, 175, 27–38.
Granado-Serrano, A. B., Martín, M. A., Bravo, L., Goya, L., & Ramos, S. (2010). Nutrition and Cancer, 62, 390–401.
Suh, D. K., Lee, E. J., Kim, H. C., & Kim, J. H. (2010). Arch Pharmacal Research, 33, 781–785.
Choi, J. A., Kim, J. Y., Lee, J. Y., Kang, C. M., Kwon, H. J., Yoo, Y. D., et al. (2001). International Journal of Oncology, 19, 837–844.
Tanigawa, S., Fujii, M., & Hou, D. X. (2008). Bioscience, Biotechnology, and Biochemistry, 72, 797–804.
Granado-Serrano, A. B., Martín, M. A., Bravo, L., Goya, L., & Ramos, S. (2006). Journal of Nutrition, 136, 2715–2721.
Serrano, M., Hannon, G. J., & Beach, D. (1993). Nature, 366, 704–707.
Park, S. H., Lim, J. S., & Jang, K. L. (2011). Cancer Letters, 310, 232–239.
Han, J., Tsukada, Y., Hara, E., Kitamura, N., & Tanaka, T. (2005). Journal of Biological Chemistry, 280, 31548–31556.
Liu, L. H., Xiao, W. H., & Liu, W. W. (2001). World Journal of Gastroenterology, 7, 131–135.
Tan, S., Wang, C., Lu, C., Zhao, B., Cui, Y., Shi, X., et al. (2009). Chemotherapy, 55, 6–10.
Hu, H., Li, Z., Chen, J., Wang, D., Ma, J., Wang, W., et al. (2011). Gut, 60, 710–721.
Lu, Y., Zhang, X., & Zhang, J. (2012). Journal of Cancer, 3, 333–344.
Daker, M., Ahmad, M., & Khoo, A. S. (2012). Cancer Cell International, 12, 34.
Demiroglu-Zergeroglu, A., Basara-Cigerim, B., Kilic, E., & Yanikkaya-Demirel, G. (2010). Journal of Biomedicine and Biotechnology, 2010, 851589.
Sharma, H., Sen, S., & Singh, N. (2005). Cancer Biology and Therapy, 4, 949–955.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhao, Jl., Zhao, J. & Jiao, Hj. Synergistic Growth-Suppressive Effects of Quercetin and Cisplatin on HepG2 Human Hepatocellular Carcinoma Cells. Appl Biochem Biotechnol 172, 784–791 (2014). https://doi.org/10.1007/s12010-013-0561-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-013-0561-z